INTRAOPERATIVE MRI
FOR BRAIN TUMOUR SURGERY
A real-time MRI scan taken during the operation — giving the surgeon a second chance to remove tumour tissue that pre-operative imaging or the naked eye would have missed.
analyticsAt a Glance
- check_circleiMRI acquires brain scans mid-surgery, before the skull is closed, to reveal remaining tumour
- check_circleImproves gross total or near-total resection rates by 20–40% compared to standard neuronavigation alone
- check_circleMost beneficial for glioblastoma, high-grade astrocytoma, and pituitary macroadenoma
- check_circleCancerFax identifies iMRI-equipped neurosurgery centres and facilitates international patient access
What Is Intraoperative MRI and Why Does It Matter?
Standard neuronavigation uses pre-operative MRI to guide tumour removal — but the brain shifts during surgery as cerebrospinal fluid drains and tissue is removed, making pre-operative images progressively inaccurate. Intraoperative MRI addresses this by acquiring new, high-resolution images during the operation, with the patient still on the operating table and the surgical field open.
“The brain is not static during surgery — pre-operative images drift by millimetres within the first 30 minutes of opening. iMRI corrects this in real time.”
The Brain Shift Problem
As CSF escapes and tissue is manipulated, the brain shifts 5–10 mm relative to pre-operative MRI coordinates — making standard neuronavigation increasingly unreliable as surgery progresses. iMRI resets this navigation baseline mid-procedure.
What iMRI Reveals
Residual contrast-enhancing tumour invisible under the surgical microscope, small satellite deposits at the resection margin, and blood or oedema that might mask incomplete resection — all visible on intraoperative gadolinium-enhanced T1 sequences.
Key Clinical Numbers for iMRI-Guided Surgery
Multiple prospective studies demonstrate that iMRI consistently improves extent of resection — the strongest independent predictor of survival in glioblastoma.
- +24%Increase in gross total resection rate with iMRI vs standard neuronavigation (GBM)A randomised controlled trial (Senft et al, Lancet Oncology 2011) showed iMRI-guided surgery achieved GTR in 96% vs 68% of GBM patients with standard neuronavigation — a 28 percentage point improvement.
- 5–10 mmTypical brain shift during glioma surgeryMeasured intraoperatively — this drift renders pre-operative neuronavigation significantly inaccurate within the first hour of surgery, directly impacting resection completeness.
- ~30%Cases where iMRI prompts further resectionIn approximately 30% of cases where the surgeon believes resection is complete, intraoperative MRI reveals residual tumour — leading to further resection before closure in a clinically meaningful proportion.
How Intraoperative MRI Works in Practice
The iMRI workflow requires purpose-built operating theatre suites with MRI-compatible equipment — a significant infrastructure investment that explains why iMRI is available only at specialist neurosurgery centres.
- 1
MRI-Compatible Operating Theatre
Surgery is performed in a hybrid theatre equipped with a high-field MRI scanner (typically 1.5T or 3T). All surgical instruments, anaesthetic equipment, and the operating table must be MRI-safe.
- 2
Standard Tumour Resection
Surgery proceeds using neuronavigation and surgical microscope as standard. The surgeon removes tumour as completely as deemed safe based on visible tissue and real-time neuromonitoring.
- 3
Wound Covered and Patient Moved to MRI
The surgical field is temporarily covered with a sterile drape, and the patient — still anaesthetised — is moved within the hybrid suite to the MRI bore for imaging.
- 4
Intraoperative MRI Acquired
Gadolinium-enhanced T1, FLAIR, and DWI sequences are acquired. Images are reviewed immediately by the surgeon and neuroradiologist to assess residual enhancing tumour.
- 5
Decision: Further Resection or Close
If residual tumour is identified and surgically accessible without unacceptable risk, the patient is returned to the operating position and further resection is performed. iMRI may be repeated.
- 6
Final Closure
Once complete resection is confirmed or safe limits are reached, wound closure proceeds. Post-operative MRI is typically acquired within 24–48 hours to document final extent of resection.
Which Brain Tumours Benefit Most from iMRI?
iMRI is most valuable for tumours where complete resection is both achievable and clinically beneficial — and where the tumour margin is difficult to see under the surgical microscope.
| Tumour Type | iMRI Benefit | Level of Evidence |
|---|---|---|
| Glioblastoma (GBM) | Maximises extent of contrast-enhancing tumour resection — strongest predictor of OS | High — RCT (Senft, Lancet Oncol 2011) |
| High-grade astrocytoma (grade 3) | Improves GTR rate; reduces residual enhancing tumour volume | Moderate — multiple prospective series |
| Low-grade glioma (IDH-mutant) | FLAIR-sequence iMRI identifies non-enhancing residual; guides FLAIR resection | Moderate — growing prospective data |
| Pituitary macroadenoma | Confirms cavernous sinus and optic chiasm decompression intraoperatively | High — well-established in pituitary surgery |
| Paediatric brain tumours | Critical for medulloblastoma and ependymoma resection — extent of resection is prognostic | Moderate — strong clinical consensus |
| Metastasis (large, symptomatic) | Confirms complete resection before closure; reduces re-operation rates | Moderate |
Frequently Asked Questions
Common questions from patients exploring iMRI-guided surgery options.
About iMRI Surgery
Does iMRI add significant time to the operation?
Yes — an intraoperative MRI scan adds approximately 45–75 minutes to the total operative time, including patient repositioning, scan acquisition, and image review. For GBM cases where further resection is indicated after the first scan, total operating time may increase by 2–3 hours. The surgical team weighs this against the clinical benefit.
Is iMRI available in China and India?
Yes. Intraoperative MRI suites are installed at Beijing Tiantan Hospital, Huashan Hospital Shanghai, and several other major academic neurosurgery centres in China. In India, AIIMS New Delhi, Fortis Gurgaon, and Apollo Chennai have established iMRI programmes. CancerFax can confirm current availability and waiting times at specific centres.
Will iMRI guarantee complete tumour removal?
No. Even with iMRI, complete resection may not be achievable if the tumour infiltrates eloquent cortex, critical vascular structures, or the brainstem. iMRI significantly increases the likelihood of maximal safe resection, but the goal is always maximum safe resection — not resection at any cost.
Does iMRI improve survival in glioblastoma?
Indirect evidence is strong. Greater extent of resection is one of the most consistent independent predictors of overall survival in GBM. iMRI's role in improving GTR rates thus plausibly translates to a survival benefit — though a large RCT specifically powered for OS outcomes has not yet been completed.
More from the Brain Tumour Treatment Resource Library
Explore related guides on brain tumour surgery techniques and access options.
- ↑ Brain Tumour Treatment — Complete Guide
- Awake Craniotomy: What It Involves, Who Needs It, and Which Centres Perform It
- 5-ALA Fluorescence-Guided Brain Tumour Surgery
- Meningioma Treatment: Surgery, Gamma Knife, and Observation
- Gamma Knife Radiosurgery for Brain Tumours: A Patient Guide
- Brain Metastases: Surgery vs Gamma Knife vs Whole Brain Radiation
How CancerFax Helps
CancerFax is a specialist cancer access and patient-navigation platform. We help patients and families understand their options, organise medical records, coordinate hospital communication, and support cross-border treatment planning where appropriate.
We help collect and organise reports, scans, pathology, biomarker results, and treatment history for structured case review.
We communicate with hospitals or trial teams to assess whether a case may be suitable for further screening.
We support appointment coordination, document submission, translation, and direct communication with international departments.
For international patients, we help with practical coordination — travel planning, hospital admission guidance, and local support.
If this option is not suitable, we help explore other relevant treatments, clinical trials, or advanced care pathways.
From inquiry through to follow-up, our coordinators provide a single point of contact for the family.
CancerFax does not guarantee treatment access, eligibility, or clinical outcome. Our role is to help patients access accurate information, structured review, and appropriate specialist pathways.
Find an iMRI-Equipped Neurosurgery Centre
CancerFax reviews your MRI imaging and tumour characteristics to identify whether iMRI-guided surgery is appropriate — and connects you with neurosurgery centres equipped with intraoperative MRI systems in China, India, and internationally.
This content is for informational purposes only and does not constitute medical advice. Always consult a qualified neurosurgeon before making treatment decisions.